insights_auto
Nega ALC oshdi 4,43%?
Batafsil oʻrganishchevron_right
ALC:NYSE
Alcon AG
70,42 US$
arrow_upward
+4,43%(+2,99) 1K
22-okt, 11:43:04 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALC tikeri uchun statistika yaratilmoqda...
Ochish
68,02 US$
Yuqori
70,46 US$
Past
67,96 US$
Bozor kapitali
28,86 mlrd
Oʻrtacha hajm
1,75 mln
Hajmi
714,89 ming
52 haftalik eng yuqori
87,64 US$
52 haftalik eng past
61,84 US$
Beta
0,88
Muomaladagi aksiyalar
483,40 mln
Xodimlar soni
25 ming
Ochish
68,02 US$
Yuqori
70,46 US$
Past
67,96 US$
Bozor kapitali
28,86 mlrd
Oʻrtacha hajm
1,75 mln
Hajmi
714,89 ming
52 haftalik eng yuqori
87,64 US$
52 haftalik eng past
61,84 US$
Beta
0,88
Muomaladagi aksiyalar
483,40 mln
Xodimlar soni
25 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Investing.com Canada
·
1 kun oldin
Alcon acquires Neurotech for $550m to expand retina portfolio By Investing.com
Yahoo Finance
·
1 kun oldin
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Alcon AG haqida
CEODavid J. Endicott
Xodimlar soni25 ming
Asos solingan1945
Bosh ofislarJeneva, Geneva, Shveytsariya
Sektor-
Veb-saytalcon.com